Scope of the Collaboration Sample Clauses

Scope of the Collaboration. The Parties hereby undertake to jointly carry out the Program in accordance with the Work Plan attached as Exhibit A hereto with the purpose of developing Licensed Products for use and sale within the Licensed Field. The Parties from time to time as recommended by the Steering Committee may adjust the Work Plan by mutual written agreement.

Scope of the Collaboration. The EWP Consortium and the Institution hereby agree to work together within the framework of the EWP Infrastructure. The scope of the collaboration is the integration of the Institution’s software with the EWP Infrastructure so that such software becomes an instrument that can be used for the connection of the Institution to the EWP Network and inclusion in the EWP Registry. This will take the form of providing access to the EWP Network through the software of the Institution itself, enabling data exchange that is compatible with the EWP standards and the Erasmus program requirements, and hence the benefits of the services implemented via such a network. This integration shall be performed under the terms and conditions stipulated herein; and as further specified in the Developers Hub.

Scope of the Collaboration. 2.1. The Parties and/or its Affiliate wish to discuss the potential collaboration and/or business transaction in the following areas (“Collaboration Areas”):- (a) [***]. 2.2. For the avoidance of doubt, “Collaboration Area” refers to each of the collaboration area specified in Clause 2.1 herein, and reference to the “Collaboration Area” shall be constructed as reference to all or any one of them, as the case may be, and where applicable.

Scope of the Collaboration. The Chapter and the Collaborating Organization agree to engage together in the following:

Scope of the Collaboration. The purpose of this MOU is to establish a reciprocal and formalized relationship between the Parties to collaborate with respect to the mutual goal of supporting the growth of the innovation ecosystem through supporting local start-ups and Subject Matter Experts (SME), attracting investment opportunities, cultivating ecosystem engagement and incubating talent within their respective jurisdictions. Specifically, the Agreement will facilitate and enable the Parties to: (i) Identify potential opportunities for collaboration based on common fields of interest in Artificial Intelligence, Life Sciences, Digitizing Health Solutions and Advanced Manufacturing to strengthen their respective leadership positions in the global market. (ii) Support collaborative works through cross-promotion, including the publishing of the other party’s logo on their respective websites, sharing of information in newsletters etc., the terms and conditions of which shall be subject to a separate agreement. (iii) Share and communicate information, unless otherwise prohibited, on an ongoing basis, including the state of technology development and commercialization activities in their respective jurisdictions, best practices, and knowledge sharing, the terms and conditions of which shall be subject to a separate agreement. (iv) Discussing mutual networking and cooperation opportunities in both regions and exploring opportunities across the innovation clusters and common verticals in both regions. (v) As permitted, establish a strategic relationship to share technological expertise and knowledge across common fields of interest and activity areas to further solidifying their jurisdictions’ positions as trade partners. The Parties agree to leverage their respective networks and resources to facilitate investment discussions and explore new cross promotion and marketing opportunities, the terms and conditions of which shall be subject to a separate agreement. (vi) Co-hosting and collaborating on bilateral and multilateral business to business meetings, events and workshops, as well as networking and participation in relevant events within their respective ecosystems, including complimentary registration to conferences and events where applicable.

Scope of the Collaboration. The EWP consortium and the Institution hereby agree to work together within the framework of the EWP Network. This will take the form of a connection of the EWP Network (as exemplified by the EWP registry) with the internationalization software of the Institution. The scope of the collaboration is the integration of the Institution’s Student Information System software with the EWP Registry Service and the APIs provided by the EWP consortium so that the Institution’s software becomes a node that can be used for the exchange of data in the higher education domain. Through this integration, the Institution offers its users access to the Network and hence the benefits of the services implemented via the EWP network. The Institution will have to be able to prove that it is officially represented as an Institution by the signer of this document.

Scope of the Collaboration. The general purpose of this Agreement is to facilitate academic and research cooperation OPTIONAL: in [insert field/area(s) of research] between the parties hereunder based upon the principles of mutual benefit and may include the following general cooperation areas: 1.1 Joint educational and research activities. 1.2 Exchange of visiting scholars for the purpose of conducting research. The individual visitors will be responsible for the cost of their accommodations and for their own travel costs. If visiting scholars register in academic course(s) they will be required to pay the normal tuition fees to the host institution. 1.3 Discussion for the exchange of undergraduate and graduate students for collaborative or independent research based on the policies of both institutions. 1.4 Exchange of scholarly information including research papers, indices to theses, books and magazines on relevant subjects and potential joint projects where possible and appropriate. 1.5 Extension of invitations for attending scholarly and technical meetings as well as national and international conferences.

Scope of the Collaboration. The Parties shall undertake the following activities in accordance with the terms of this Agreement, all of which shall together comprise the “Collaboration” for the purposes of this Agreement: 2.1 In the first stage of the Collaboration the Parties shall undertake a joint research program for the purpose of developing a Product or Products, which shall potentially have application in both Parties’ therapeutic area of interest. Such program shall include all research required for the development of such Products towards submission of an IND up to and including the Proof of Concept studies in animals, in accordance with the provisions of Section 3 herein (the “Joint Research Stage”); 2.2 In the second stage of the Collaboration, following the Joint Research Stage, each Party or its sublicensee shall independently undertake, at its own expense, such further pre-clinical and clinical drug development activities as are necessary to obtain Regulatory Approvals for the commercialization of Products in such Party’s therapeutic area of interest (the “Development Stage”). During the Development Stage of Collaboration the Parties shall determine which, if any, Formal Preclinical Development or Clinical Development studies are suitable to both Parties’ therapeutic category of interest and benefit both their Formal Preclinical Development or Clinical Development and shall cooperate with each other in the performance of such studies, in accordance with the provisions of Section 4.3 herein (the “Joint Development Program” ).

Scope of the Collaboration. The parties hereby agree to establish and conduct, during the Research Term, a collaborative research program in accordance with the Research Plan and the terms of this Agreement. The initial Research Plan for conducting such research program is attached hereto as Exhibit B. Pursuant to the Collaboration, the parties will collaborate in (a) identifying receptor-selective adrenergic and prostanoid lead compounds, (b) identifying receptor-selective lead compounds with respect to other receptor targets, (c) facilitating the development of gene to screen discovery capabilities by developing receptor arrays and probes specific for G-protein coupled and other receptors, (d) identifying candidate receptors and markers for [***], (e) establishing ACADIA drug discovery programs which leverage certain results of the Collaboration for the benefit of both parties and directed at ACADIA Designated Uses, and (f) conducting such other activities as are unanimously approved by the RMC.